|
RIOK2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.85319999976986E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.26309999967955E-07 |
| Normal-vs-Stage2 |
6.299300E-03 |
| Normal-vs-Stage3 |
4.899200E-01 |
| Normal-vs-Stage4 |
9.255000E-01 |
| Stage1-vs-Stage2 |
6.944000E-01 |
| Stage1-vs-Stage3 |
3.369800E-02 |
| Stage1-vs-Stage4 |
2.161200E-01 |
| Stage2-vs-Stage3 |
1.972410E-01 |
| Stage2-vs-Stage4 |
2.907200E-01 |
| Stage3-vs-Stage4 |
6.522800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.64840000053069E-07 |
| Normal-vs-AfricanAmerican |
1.103160E-03 |
| Normal-vs-Asian |
6.906800E-01 |
| Caucasian-vs-AfricanAmerican |
6.453800E-01 |
| Caucasian-vs-Asian |
4.501700E-02 |
| AfricanAmerican-vs-Asian |
8.034500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.70230000388017E-08 |
| Normal-vs-Female |
4.098400E-02 |
| Male-vs-Female |
1.045640E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.141500E-03 |
| Normal-vs-Extreme_Weight |
1.4183999996753E-07 |
| Normal-vs-Obese |
6.075500E-03 |
| Normal-vs-Extreme_Obese |
7.699800E-02 |
| Normal_Weight-vs-Extreme_Weight |
3.901000E-01 |
| Normal_Weight-vs-Obese |
6.701400E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.816200E-01 |
| Extreme_Weight-vs-Obese |
9.659800E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.764400E-01 |
| Obese-vs-Extreme_Obese |
4.680800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.688200E-02 |
| Normal-vs-Age(41-60Yrs) |
4.961000E-03 |
| Normal-vs-Age(61-80Yrs) |
2.38330000179587E-08 |
| Normal-vs-Age(81-100Yrs) |
1.300370E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.683600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.318800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.065600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.066250E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.822000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.037800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.18480011859867E-10 |
| Normal-VS-Type2 PRCC |
2.703600E-01 |
| Normal-VS-KIRP CIMP |
2.596400E-04 |
| Normal-VS-Unclassified PRCC |
4.587800E-02 |
| Type1 PRCC-VS-Type2 PRCC |
7.567600E-04 |
| Type1 PRCC-VS-KIRP CIMP |
7.401400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.584300E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.547800E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
3.956600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.389600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.829200E-04 |
| Normal-vs-N1 |
5.759000E-01 |
| Normal-vs-N2 |
5.719900E-03 |
| N0-vs-N1 |
5.438500E-03 |
| N0-vs-N2 |
7.387600E-01 |
| N1-vs-N2 |
1.778850E-01 |
|
|
